Recombinant Human aFGF Protein

簡要描述：Recombinant Human aFGF Protein
Less than 1 EU/μg of Recombinant HumanaFGF as determined by LAL method.

產(chǎn)品型號：abs00875
廠商性質(zhì)：生產(chǎn)廠家
更新時間：2025-11-14
訪問量：1537

產(chǎn)品咨詢聯(lián)系我們

產(chǎn)品分類

Product Category

細(xì)胞生物學(xué)

重組蛋白原代細(xì)胞分離細(xì)胞培養(yǎng) 細(xì)胞檢測細(xì)胞/組織處理外泌體研究其它動物血清 3D/類器官培養(yǎng)

查看全部

相關(guān)文章

詳細(xì)介紹

品牌	absin	純度	> 95 % by SDS-PAGE and HPLC analyses.
貨號	abs00875	規(guī)格	10ug
供貨周期	現(xiàn)貨	主要用途	Lyophilized from a 0.2 μm filtered conce
應(yīng)用領(lǐng)域	化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

Recombinant Human aFGF Protein

概述
別名	aFGF蛋白
種屬	Human
來源	Escherichia coli.
形態(tài)	Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.
性能
序列	MFNLPPGNYK KPKLLYCSNG GHFLRILPDG TVDGTRDRSD QHIQLQLSAE SVGEVYIKST ETGQYLAMDT DGLLYGSQTP NEECLFLERL EENHYNTYIS KKHAEKNWFV GLKKNGSCKR GPRTHYGQKA ILFLPLPVSS D
標(biāo)簽	No Tag
純度	> 95 % by SDS-PAGE and HPLC analyses.
內(nèi)毒素水平	Less than 1 EU/μg of Recombinant HumanaFGF as determined by LAL method.
活性	Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using murine balb/c 3T3 cells is less than 0.5 ng/ml, corresponding to a specific activity of > 2.0 × 106 IU/mg in the presence of 10 μg/ml of heparin.
溶解方法	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
儲存/保存方法	This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
靶標(biāo)
Accession	P05230
Gene IDs	2246
參考文獻
參考文獻	1. Dionne CA, Crumley G, Bellot F, et al. 1990. EMBO J. 9:2685-92. 2. Jaye M, Howk R, Burgess W, et al. 1986. Science. 233:541-5. 3. Armelin HA. 1973. Proc Natl Acad Sci U S A. 70:2702-6. 4. Gospodarowicz D. 1974. Nature. 249:123-7. 5. Zhang X, Ibrahimi OA, Olsen SK, et al. 2006. J Biol Chem. 281:15694-700. 6. Ornitz DM, Xu J, Colvin JS, et al. 1996. J Biol Chem. 271:15292-7. 7. Eswarakumar VP, Lax I, Schlessinger J. 2005. Cytokine Growth Factor Rev. 16:139-49. 8. Landriscina M, Bagala C, Mandinova A, et al. 2001. J Biol Chem. 276:25549-57. 9. Fernandez IS, Cuevas P, Angulo J, et al. 2010. J Biol Chem. 285:11714-29.

研究領(lǐng)域
研究領(lǐng)域	CancerGrowth factorsFGF CardiovascularAngiogenesisGrowth FactorsFGFFGF NeuroscienceProcesses Signal TransductionGrowth Factors/HormonesFGF

Recombinant Human aFGF Protein溫馨提示：本產(chǎn)品僅作科研實驗使用，不支持臨床等研究

產(chǎn)品咨詢

留言框

產(chǎn)品：
您的單位：
您的姓名：
聯(lián)系電話：
常用郵箱：
省份：
詳細(xì)地址：
補充說明：
驗證碼：

請輸入計算結(jié)果（填寫阿拉伯?dāng)?shù)字），如：三加四=7

上一篇：abs00876Recombinant Human aFGF, 2-155a.a.
下一篇：abs04219Recombinant Rat VEGF-A

Recombinant Human aFGF Protein

留言框

產(chǎn)品：

您的單位：

您的姓名：

聯(lián)系電話：

常用郵箱：

省份：

詳細(xì)地址：

補充說明：

驗證碼：